Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Clinical trial NCT07486726 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07486726
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Relapse Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia (AML)

Start date: 2026-03-15
Primary completion: 2027-10-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.